The MOOC “The new plastics economy: circular business models and sustainability”, realized within the Horizon 2020 BIO-PLASTICS EUROPE project
One of the greatest difficulties in combating viral infectious diseases is the excellent adaptability of viruses. Especially with of SARS-CoV-2 new variants are quickly and constantly forming, bringing different properties with them. That’s why it’s important that in the future it will be crucial to predict more quickly and precisely how dangerous a virus can become.
You have a complex chemical process that is no longer competitive? Countries with low salary levels are beginning to gain market share for cost reasons? Let acib solve your problems by discovering new and cost-efficient routes for chemo-enzymatic synthesis of your target compound(s).
acib developed a biotechnological based technology for the recycling of waste pharmaceutical blisters. Aluminium and plastic can be recovered by applying the concept of green chemistry.
Wastewater-based detection of emerging diseases has been proven to be a powerful tool during the COVID-19 pandemic. Now it’s high time to switch from a time-consuming manual and decentralized process to a fully-automated multiple-disease detection and surveillance system.
An intact microbiome protects our skin as a natural shield against external influences. However, if this sensitive system is disturbed, it can lead to serious
The pharmaceutical industry has had to resort to rather inefficient, environmentally harmful chemical synthesis routes for the production of the active ingredient levetiracetam, a drug
Gut ein Jahr nach dem Ausbruch der Coronavirus-Pandemie ist sie den meisten Menschen ein Begriff: die Polymerase-Kettenreaktion, kurz PCR (englisch: polymerase chain reaction). Sie ist
Like any virus, SARS-CoV-2 is constantly changing. A wide variety of mutations are the result, to which vaccine manufacturers have so far only been able
Researchers from TU Graz and acib succeed in the first enzyme-driven biocatalytic synthesis of nucleic acid building blocks. This facilitates the development of antiviral agents